The COVID-19 epidemic

Thirumalaisamy P Velavan, Christian G Meyer, Thirumalaisamy P Velavan, Christian G Meyer

No abstract available

Keywords: 2019-nCoV; COVID-19; Epidemic; SARS-CoV2; Wuhan.

References

    1. Coronavirus 2019‐nCoV, CSSE . Coronavirus 2019‐nCoV Global Cases by Johns Hopkins CSSE. (Available from: )
    1. Tyrrell DA, Bynoe ML. Cultivation of viruses from a high proportion of patients with colds. Lancet 1966: 1: 76–77.
    1. GISAID Global Initiative on Sharing All Influenza Data . Phylogeny of SARS‐like betacoronaviruses including novel coronavirus (nCoV). (Available from: ).
    1. Zhou P, Yang XL, Wang XG et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020. 10.1038/s41586-020-2012-7
    1. Rottier PJM. The Coronaviridae. Siddell SG, editor. 115‐137. 2013. Springer Science & Business Media. (Available from: ).
    1. Chan JF, Yuan S, Kok KH et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person‐to‐person transmission: a study of a family cluster. Lancet 2020. S0140-6736(20) 30154-9. 10.1016/S0140-6736(20)30154-9
    1. Li Q, Guan X, Wu P et al. Early transmission dynamics in Wuhan, China, of novel coronavirus‐infected pneumonia. N Engl J Med 2020. 10.1056/NEJMoa2001316
    1. Guan W, Ni Z, Yu H, et al.Clinical characteristics of 2019 novel coronavirus infection in China. medRxiv preprint posted online on Feb. 9, 2020; 10.1101/2020.02.06.20020974.
    1. Bauch CT, Lloyd‐Smith JO, Coffee MP, Galvani AP. Dynamically modeling SARS and other newly emerging respiratory illnesses: past, present, and future. Epidemiology 2005: 6: 791–801.
    1. Zhao S, Lin Q, Ran J, et al. Preliminary estimation of the basic reproduction number of novel coronavirus (2019‐nCoV) in China, from 2019 to 2020: A data‐driven analysis in the early phase of the outbreak. Int J Infect Dis 2020. S1201-9712(20)30053-9. 10.1016/j.ijid.2020.01.050
    1. 10.1016/j.ijid.2020.01.050 World Health Organization . Cumulative Number of Reported Probable Cases of Severe Acute Respiratory Syndrome (SARS). 2020. (Available from: .)
    1. World Health Organization . WHO 2019, Middle East respiratory syndrome coronavirus (MERS‐CoV). (Available from: .)
    1. Richardson P, Griffin I, Tucker C et al. Baricitinib as potential treatment for 2019‐nCoV acute respiratory disease. Lancet 2020. S0140-6736(20)30304-4. 10.1016/S0140-6736(20)30304-4
    1. Holshue ML, DeBolt C, First Lindquist S et al. Novel Coronavirus in the United States. N Engl J Med 2019.
    1. Wang M, Cao R, Zhang L et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019‐nCoV) in vitro. Cell Res 2020. 10.1038/s41422-020-0282-0
    1. Kono M, Tatsumi K, Imai AM, Saito K, Kuriyama T, Shirasawa H. Inhibition of human coronavirus 229E infection in human epithelial lung cells (L132) by chloroquine: involvement of p38 MAPK and ERK. Antiviral Res 2008: 77: 150–152.
    1. Chu CM. Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings. Thorax 2004: 59: 252–256.
    1. Available from: ; Accessed February 10, 2020.
    1. Available from: Accessed on February 10, 2020.

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する